Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast

International Journal of DermatologyEarly View Clinical Correspondence Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast Miguel Mansilla-Polo, Corresponding Author Miguel Mansilla-Polo [email protected] orcid.org/0000-0001-6730-6723 Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this authorCarlos Abril-Pérez, Carlos Abril-Pérez Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this authorDaniel Martín-Torregrosa, Daniel Martín-Torregrosa orcid.org/0009-0008-7918-4733 Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this authorRafael Botella-Estrada, Rafael Botella-Estrada Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain Universitat de València, Valencia, SpainSearch for more papers by this authorIgnacio Torres-Navarro, Ignacio Torres-Navarro Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this author Miguel Mansilla-Polo, Corresponding Author Miguel Mansilla-Polo [email protected] orcid.org/0000-0001-6730-6723 Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this authorCarlos Abril-Pérez, Carlos Abril-Pérez Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this authorDaniel Martín-Torregrosa, Daniel Martín-Torregrosa orcid.org/0009-0008-7918-4733 Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this authorRafael Botella-Estrada, Rafael Botella-Estrada Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, Spain Universitat de València, Valencia, SpainSearch for more papers by this authorIgnacio Torres-Navarro, Ignacio Torres-Navarro Department of Dermatology, Hospital Universitario y Politécnico La Fe, Valencia, Spain Instituto de Investigación Sanitaria (IIS) La Fe, Valencia, SpainSearch for more papers by this author First published: 06 June 2024 https://doi.org/10.1111/ijd.17293 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Chen KH, Lin CY, Su SB, Chen KT. Leprosy: a review of epidemiology, clinical diagnosis, and management. J Trop Med. 2022; 2022(4):8652062. 10.1155/2022/8652062 PubMedGoogle Scholar 2Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006; 19(2): 338–381. 10.1128/CMR.19.2.338-381.2006 CASPubMedWeb of Science®Google Scholar 3Abril-Pérez C, Palacios-Diaz RD, Navarro-Mira MÁ, Botella-Estrada R. Successful treatment of erythema nodosum leprosum with apremilast. Dermatol Ther. 2022; 35(3):e15258. 10.1111/dth.15258 CASPubMedWeb of Science®Google Scholar 4Mohamed MF, Bhatnagar S, Parmentier JM, Nakasato P, Wung P. Upadacitinib: mechanism of action, clinical, and translational science. Clin Transl Sci. 2023; 17(1):e13688. 10.1111/cts.13688 PubMedWeb of Science®Google Scholar 5Mansilla-Polo M, Gimeno E, Morgado-Carrasco D. Topical and oral roflumilast in dermatology: a narrative review. Actas Dermosifiliogr. 2024; 115(3): 265–279. 10.1016/j.ad.2023.09.005 CASPubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation